Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Norton

Showing results (471-480 of 523) with videos related to

Pageof 53
Sort By:
European Journal of Cancer (Oxford, England : 1990)|February 21, 1998
Phase II study of semisynthetic paclitaxel in metastatic breast cancerC Hudis, L Riccio, F Holmes, et al.
Science (New York, N.Y.)|November 2, 2023
In Science JournalsMelissa L Norton, Jelena Stajic, Dale Dorsett, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1996
Ninety-six-hour paclitaxel infusion after progression during short taxane exposure: a phase II pharmacokinetic and pharmacodynamic study in metastatic breast cancerA D Seidman, D Hochhauser, M Gollub, et al.
Drug and Alcohol Dependence|February 14, 2026
Achieving SVR is associated with long term reduced hazardous alcohol use for people who inject drugs receiving HCV treatment: The HERO studyEmily Waters, Jessica Obeysekare, Snehal Lopes, et al.
Journal of Hepatology|January 19, 2024
Optimal hepatitis C treatment adherence patterns and sustained virologic response among people who inject drugs: The HERO studyMoonseong Heo, Brianna L Norton, Irene Pericot-Valverde, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999
5-year results of dose-intensive sequential adjuvant chemotherapy for women with high-risk node-positive breast cancer: A phase II studyC Hudis, M Fornier, L Riccio, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 15, 2001
Immunization of metastatic breast cancer patients with a fully synthetic globo H conjugate: a phase I trialT Gilewski, G Ragupathi, S Bhuta, et al.
Science (New York, N.Y.)|May 14, 2026
In Science JournalsSacha Vignieri, Angela Hessler, Phil Szuromi, et al.
Science (New York, N.Y.)|May 28, 2026
In Science JournalsKeith T Smith, Angela Hessler, Jack Huang, et al.
Science (New York, N.Y.)|April 3, 2025
In Science JournalsSacha Vignieri, Mattia Maroso, Michael A Funk, et al.
Pageof 53

Showing results (471-480 of 523) with videos related to

Sort By:
Pageof 53
European Journal of Cancer (Oxford, England : 1990)|February 21, 1998
Phase II study of semisynthetic paclitaxel in metastatic breast cancerC Hudis, L Riccio, F Holmes, et al.
Science (New York, N.Y.)|November 2, 2023
In Science JournalsMelissa L Norton, Jelena Stajic, Dale Dorsett, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1996
Ninety-six-hour paclitaxel infusion after progression during short taxane exposure: a phase II pharmacokinetic and pharmacodynamic study in metastatic breast cancerA D Seidman, D Hochhauser, M Gollub, et al.
Drug and Alcohol Dependence|February 14, 2026
Achieving SVR is associated with long term reduced hazardous alcohol use for people who inject drugs receiving HCV treatment: The HERO studyEmily Waters, Jessica Obeysekare, Snehal Lopes, et al.
Journal of Hepatology|January 19, 2024
Optimal hepatitis C treatment adherence patterns and sustained virologic response among people who inject drugs: The HERO studyMoonseong Heo, Brianna L Norton, Irene Pericot-Valverde, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999
5-year results of dose-intensive sequential adjuvant chemotherapy for women with high-risk node-positive breast cancer: A phase II studyC Hudis, M Fornier, L Riccio, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 15, 2001
Immunization of metastatic breast cancer patients with a fully synthetic globo H conjugate: a phase I trialT Gilewski, G Ragupathi, S Bhuta, et al.
Science (New York, N.Y.)|May 14, 2026
In Science JournalsSacha Vignieri, Angela Hessler, Phil Szuromi, et al.
Science (New York, N.Y.)|May 28, 2026
In Science JournalsKeith T Smith, Angela Hessler, Jack Huang, et al.
Science (New York, N.Y.)|April 3, 2025
In Science JournalsSacha Vignieri, Mattia Maroso, Michael A Funk, et al.
Pageof 53